Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
-
Palestinians to vote in first elections since Gaza war
-
Pragmatism, not patriotism, pushes young Lithuanians to military service
-
Peru confirms election runoff date, court says no to Lima re-vote
-
Venezuela, Colombia pledge military cooperation on first post-Maduro visit
-
US hopes for progress, but Iran says not direct talks
-
Maine governor nixes data center moratorium in state
-
Betis's Bellerin further dents Real Madrid title hopes
-
Lens rally but title bid fades after draw at Brest
-
OpenAI CEO apologizes to Canada town for not reporting mass shooter
-
UK PM vows legislation to ban Iran Guards: report
-
Leipzig tighten top-four grip as Union's Eta suffers second loss
-
Furyk named USA captain for 2027 Ryder Cup
-
EU, US sign critical minerals plan to counter China reliance
-
The 'housewives' did well -- Ukraine takes drone know-how abroad
-
Court removes US businessman from managing his Brazilian football team
-
'Natural' birth control risks unwanted pregnancy, experts warn
-
No.2 Korda boosts LPGA Chevron lead to seven
-
EU trade chief seeks 'positive traction' on US steel tariffs
-
Anthropic says Google to pump $40 bn into AI startup
-
Kohli makes Gujarat pay as Bengaluru cruise to IPL win
-
One injured in bomb attack on Colombia military base
-
Envoys from Iran, US expected in Pakistan for new talks
-
ILO names US official as number two amid grumbling over unpaid dues
-
Son of director Rob Reiner pays tribute to slain parents
-
AI united Altman and Musk, then drove them apart
-
Sinner overcomes Bonzi in record hunt at Madrid Open
-
Havana property market stirs as investors bet on political change
-
Children's lives at risk from US funding cuts to vaccine alliance: CEO
-
Brazil's Lula has surgery to remove skin lesion from scalp
-
Defending champion Alcaraz to miss French Open with wrist injury
-
Battle lines drawn over EU's next big budget
-
Renewed hopes of Iran peace talks keep oil under $100 per barrel
-
Lebanon truce extended as Pakistan bids to revive US-Iran talks
-
Assisted dying bill scuppered as UK advocates vow to fight on
-
Alex Marquez quickest in Spanish MotoGP practice
-
Former New Zealand cricketer Bracewell given two-year ban for cocaine use
-
Justice Dept ends criminal probe into US Fed chair Powell
-
Merz says no 'immediate' Ukraine EU membership, floats Kyiv joining meetings
-
G7 says nature talks a success as climate sidelined for US
-
'Hands off': Teddy bear tale teaches French preschoolers consent
-
Russia, Ukraine swap 193 POWs
-
'We have to be stronger': De Zerbi demands Spurs improve as relegation fears mount
-
Man City will not risk Rodri in FA Cup semi-final: Guardiola
-
Macron leaves future open as political curtain nears
-
Germany launches spying probe into Signal attacks targeting MPs
-
Arsenal haven't given up on title despite blowing lead: Arteta
-
Injured Spain star Yamal will come back stronger at World Cup: Flick
-
Oil prices fall on hopes of fresh Iran peace talks
-
Chelsea can still save season despite slump: McFarlane
-
Echoing Diana, Prince Harry visits Ukraine's deminers
Bionoid Pharma, Inc. Rebrands as AI Maverick Intel, Inc. to Reflect Strategic Shift Toward AI-Driven Innovation
NEW YORK CITY, NEW YORK / ACCESS Newswire / May 16, 2025 / Bionoid Pharma Inc. (OTC PINK:BINP) proudly announces its corporate rebranding to AI Maverick Intel, Inc., marking a significant transformation in its strategic direction. This change underscores the company's commitment to leveraging advanced artificial intelligence technologies to revolutionize customer acquisition and engagement across healthcare, biotech, and other sectors.
The rebranding follows the successful acquisition of AI Maverick Intel, a leading platform renowned for its proprietary AI solutions that automate and enhance audience engagement. The platform's capabilities enable intelligent, two-way communication and data-driven interactions, positioning the company at the forefront of AI-driven business solutions.
"Our evolution into AI Maverick Intel, Inc. signifies more than a name change; it represents our dedication to pioneering AI technologies that drive meaningful engagement and sustainable growth," said Wayne Cockburn, CEO of AI Maverick Intel, Inc. "By integrating cutting-edge AI solutions, we are poised to deliver unparalleled value to our clients and stakeholders."
The company's flagship AI Maverick platform is designed to streamline customer acquisition processes, enabling businesses to identify, reach, and engage their target audiences with unprecedented efficiency and precision. This strategic shift aligns with the company's vision to become a leader in AI-driven solutions that foster innovation and long-term value creation.
For more information about AI Maverick Intel, Inc. and its innovative AI solutions, please visit https://aimaverickintel.com/
About Bionoid Pharma Inc.
Bionoid Pharma Inc. is a growth-oriented AI company focused on acquiring and enhancing revenue-generating businesses through its proprietary AI Maverick platform. The technology enables intelligent, two-way communication and data-driven engagement across healthcare, biotech, and other sectors. Bionoid aims to deliver long-term value through innovation, efficiency, and strategic partnerships.
Stay Connected:
Website | AI Maverick | OTC:BINP | X: @BionoidPharminc
Media Contact:
Wayne Cockburn, CEO
(905) 505-0770
Email: [email protected]
SOURCE: Bionoid Pharma Inc.
View the original press release on ACCESS Newswire
A.Jones--AMWN